Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48,041,653
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
49,891,551
-
Shares change
-
+2,212,725
-
Total reported value, excl. options
-
$1,074,666,783
-
Value change
-
+$46,085,035
-
Number of buys
-
110
-
Number of sells
-
-76
-
Price
-
$21.54
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q2 2025
223 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q2 2025.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,891,551 shares
.
Largest 10 shareholders include Casdin Capital, LLC (7,707,165 shares), BlackRock, Inc. (5,537,601 shares), T. Rowe Price Investment Management, Inc. (4,246,706 shares), Invesco Ltd. (3,580,778 shares), VANGUARD GROUP INC (2,897,270 shares), STATE STREET CORP (1,408,955 shares), FRED ALGER MANAGEMENT, LLC (1,248,028 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,102,091 shares), AMERIPRISE FINANCIAL INC (1,080,371 shares), and Rockefeller Capital Management L.P. (1,026,415 shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.